Little Green Pharma Ltd (ASX:LGP)
Australia · Delayed Price · Currency is AUD 0.0770
-0.0040 (-4.94%)
Jun 19, 2026, 4:10 PM AEST
Little Green Pharma Income Statement
Financials in millions AUD. Fiscal year is April - March.
Millions AUD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 42.43 | 36.82 | 25.63 | 19.86 | 14.04 |
Other Revenue | - | 0.02 | 1.49 | - | - |
| 42.43 | 36.84 | 27.12 | 19.86 | 14.04 | |
Revenue Growth (YoY) | 15.16% | 35.85% | 36.55% | 41.45% | 100.47% |
Cost of Revenue | 12.28 | 11.9 | 6.22 | 6.06 | 6.69 |
Gross Profit | 30.14 | 24.94 | 20.9 | 13.8 | 7.35 |
Selling, General & Admin | 22.94 | 22.04 | 22.37 | 19.52 | 25.66 |
Research & Development | 0.05 | 0.29 | 0.58 | 1.47 | 4.06 |
Other Operating Expenses | 0.01 | 0.01 | 0.07 | - | - |
Operating Expenses | 28.02 | 28.47 | 28.35 | 20.98 | 29.72 |
Operating Income | 2.12 | -3.53 | -7.45 | -7.18 | -22.37 |
Interest Expense | -0.44 | -0.29 | -0.58 | -0.93 | -0.72 |
Interest & Investment Income | 0.07 | 0.02 | 0.17 | 0.05 | 0.04 |
Currency Exchange Gain (Loss) | 0.04 | -0.05 | 0.01 | -0.56 | -1.35 |
Other Non Operating Income (Expenses) | -0.11 | -0.09 | -0.06 | 0.06 | 0.33 |
EBT Excluding Unusual Items | 1.68 | -3.95 | -7.91 | -8.56 | -24.07 |
Asset Writedown | -3.3 | -0.85 | -0.24 | - | - |
Pretax Income | -1.54 | -4.79 | -8.15 | -8.56 | -24.07 |
Income Tax Expense | -0.14 | -8.12 | - | - | - |
Earnings From Continuing Operations | -1.41 | 3.32 | -8.15 | -8.56 | -24.07 |
Earnings From Discontinued Operations | - | - | - | -0.65 | -0.31 |
Net Income | -1.41 | 3.32 | -8.15 | -9.21 | -24.38 |
Net Income to Common | -1.41 | 3.32 | -8.15 | -9.21 | -24.38 |
Shares Outstanding (Basic) | 305 | 302 | 300 | 250 | 236 |
Shares Outstanding (Diluted) | 305 | 302 | 300 | 250 | 236 |
Shares Change (YoY) | 0.93% | 0.89% | 19.91% | 5.90% | 42.33% |
EPS (Basic) | -0.00 | 0.01 | -0.03 | -0.04 | -0.10 |
EPS (Diluted) | -0.00 | 0.01 | -0.03 | -0.04 | -0.10 |
Free Cash Flow | -0.79 | -1.15 | -0.65 | -8.76 | -33.07 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.04 | -0.14 |
Gross Margin | 71.05% | 67.70% | 77.07% | 69.50% | 52.38% |
Operating Margin | 5.00% | -9.59% | -27.48% | -36.17% | -159.33% |
Profit Margin | -3.32% | 9.02% | -30.06% | -46.35% | -173.66% |
Free Cash Flow Margin | -1.86% | -3.13% | -2.39% | -44.10% | -235.51% |
EBITDA | 5.44 | -0.28 | -4.57 | -4.35 | -21.06 |
EBITDA Margin | 12.81% | -0.76% | -16.87% | -21.90% | -150.01% |
D&A For EBITDA | 3.31 | 3.25 | 2.88 | 2.83 | 1.31 |
EBIT | 2.12 | -3.53 | -7.45 | -7.18 | -22.37 |
EBIT Margin | 5.00% | -9.59% | -27.48% | -36.17% | -159.33% |
Revenue as Reported | - | - | - | - | 14.04 |